eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Reconstructive Surgery

Drooling: Workup

Author: Neeraj N Mathur, MBBS, MS, Professor, Department of Ear, Nose and Throat, Lady Hardinge Medical College and Associated Smt SK and Kalawati, Saran Children's Hospital, University of Delhi, India; Professor and Head, Department of Ear, Nose and Throat, BP Koirala Institute of Health Sciences, Nepal
Contributor Information and Disclosures

Updated: Nov 12, 2008

Workup

Laboratory Studies

  • Salivary flow rate (mL/min): increase in weight of dental rolls/time of collection The absorbent dental rolls can be kept directly at the orifices of large salivary glands
  • Drooling Quotient : 40 observations in 10 minutes (every 15 minutes) DQ% = 100 x number of drooling episodes/40
  • Teacher Drooling Scale: 1-5 1= no drooling3= occasional drooling5= constantly wet saliva leaking on clothes and furniture

Imaging Studies

  • Lateral neck film: Adenoid hypertrophy can be confirmed if the patient has a history of nasal obstruction. Complete the adenoidectomy prior to further surgical intervention to neutralize the effects of mouth breathing on drooling.
  • Modified barium swallow: Some authors recommend performing this study to help rule out the contraindications to surgical therapy, including esophageal motility disorders, esophageal spasm, or aspiration.
  • Radiosialography: For some authors and for research purposes, these scans using radioisotope are useful for evaluating the secretory function of the salivary gland when assessing the success of surgical therapy.

Other Tests

  • Audiogram: Perform this study on patients being considered for tympanic neurectomy or chorda tympani nerve section because unilateral hearing impairment is a contraindication because of the risk of hearing loss associated with the procedures.
  • Flexible nasopharyngoscopy: This is an alternative method to assess the amount of adenoid tissue if the patient has history findings suggestive of nasal obstruction.

More on Drooling

Overview: Drooling
Workup: Drooling
Treatment: Drooling
Multimedia: Drooling
References

References

  1. Jongerius PH, van Hulst K, van den Hoogen FJ, et al. The treatment of posterior drooling by botulinum toxin in a child with cerebral palsy. J Pediatr Gastroenterol Nutr. Sep 2005;41(3):351-3. [Medline].

  2. von Lindern JJ, Niederhagen B, Appel T, et al. New prospects in the treatment of traumatic and postoperative parotid fistulas with type A botulinum toxin. Plast Reconstr Surg. Jun 2002;109(7):2443-5. [Medline].

  3. Laskawi R, Drobik C, Schönebeck C. Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome). Laryngoscope. Mar 1998;108(3):381-4. [Medline].

  4. Lim YC, Choi EC. Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment. Eur Arch Otorhinolaryngol. Feb 2008;265(2):243-5. [Medline].

  5. Manrique D. Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis. Braz J Otorhinolaryngol. Sep-Oct 2005;71(5):566-9. [Medline].

  6. Costa J, Rocha ML, Ferreira J, et al. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis. J Neurol. Apr 2008;255(4):545-50. [Medline].

  7. Marina MB, Sani A, Hamzaini AH, et al. Ultrasound-guided botulinum toxin A injection: an alternative treatment for dribbling. J Laryngol Otol. Jun 2008;122(6):609-14. [Medline].

  8. Neppelberg E, Haugen DF, Thorsen L, et al. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis. Eur J Neurol. Dec 2007;14(12):1373-7. [Medline].

  9. Postma AG, Heesters M, van Laar T. Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism. Mov Disord. Dec 2007;22(16):2430-5. [Medline].

  10. Shott SR, Myer CM 3rd, Cotton RT. Surgical management of sialorrhea. Otolaryngol Head Neck Surg. Jul 1989;101(1):47-50. [Medline].

  11. Wilkie TF. The problem of drooling in cerebral palsy: a surgical approach. Can J Surg. Jan 1967;10(1):60-7. [Medline].

  12. Bailey CM, Wadsworth PV. Treatment of the drooling child by submandibular duct transposition. J Laryngol Otol. Nov 1985;99(11):1111-7. [Medline].

  13. Bax M. Drooling. Dev Med Child Neurol. Oct 1992;34(10):847-8. [Medline].

  14. Blasco PA, Allaire JH. Drooling in the developmentally disabled: management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol. Oct 1992;34(10):849-62. [Medline].

  15. Blasco PA, Stansbury JC. Glycopyrrolate treatment of chronic drooling. Arch Pediatr Adolesc Med. Sep 1996;150(9):932-5. [Medline].

  16. Brundage SR, Moore WD. Submandibular gland resection and bilateral parotid duct ligation as a management for chronic drooling in cerebral palsy. Plast Reconstr Surg. Mar 1989;83(3):443-6. [Medline].

  17. Burton MJ. The surgical management of drooling. Dev Med Child Neurol. Dec 1991;33(12):1110-6. [Medline].

  18. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, et al. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol. Jun 1989;31(3):309-19. [Medline].

  19. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, et al. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol. Jun 1989;31(3):309-19. [Medline].

  20. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, et al. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol. Jun 1989;31(3):309-19. [Medline].

  21. Cotton RT, Richardson MA. The effect of submandibular duct rerouting in the treatment of sialorrhea in children. Otolaryngol Head Neck Surg. Jul-Aug 1981;89(4):535-41. [Medline].

  22. Crysdale WS. Drooling. Experience with team assessment and management. Clin Pediatr (Phila). Feb 1992;31(2):77-80. [Medline].

  23. Crysdale WS. Management options for the drooling patient. Ear Nose Throat J. Nov 1989;68(11):820, 825-6, 829-30. [Medline].

  24. Crysdale WS. The drooling patient: evaluation and current surgical options. Laryngoscope. May 1980;90(5 Pt 1):775-83. [Medline].

  25. Crysdale WS, Gaffney RJ. The management of drooling (Chapter 53). In: Bluestone CD, Stool SE, Kenna MA, eds. Pediatric Otolaryngology. Philadelphia: Saunders; 1996:974-983.

  26. Crysdale WS, White A. Submandibular duct relocation for drooling: a 10-year experience with 194 patients. Otolaryngol Head Neck Surg. Jul 1989;101(1):87-92. [Medline].

  27. Dundas DF, Peterson RA. Surgical treatment of drooling by bilateral parotid duct ligation and submandibular gland resection. Plast Reconstr Surg. Jul 1979;64(1):47-51. [Medline].

  28. Glass LW, Nobel GL, Vecchione TR. Treatment of uncontrolled drooling by bilateral excision of submaxillary glands and parotid duct ligations. Plast Reconstr Surg. Oct 1978;62(4):523-6. [Medline].

  29. Gordon C, Ben-Aryeh H, Attias J, et al. Effect of transdermal scopolamine on salivation. J Clin Pharmacol. Sep 1985;25(6):407-12. [Medline].

  30. Kapila YV, Dodds WJ, Helm JF, et al. Relationship between swallow rate and salivary flow. Dig Dis Sci. Jun 1984;29(6):528-33. [Medline].

  31. Klem C, Mair EA. Four-duct ligation: a simple and effective treatment for chronic aspiration from sialorrhea. Arch Otolaryngol Head Neck Surg. Jul 1999;125(7):796-800. [Medline].

  32. Lespargot A, Langevin MF, Muller S, et al. Swallowing disturbances associated with drooling in cerebral-palsied children. Dev Med Child Neurol. Apr 1993;35(4):298-304. [Medline].

  33. Lew KM, Younis RT, Lazar RH. The current management of sialorrhea. Ear Nose Throat J. Feb 1991;70(2):99-105. [Medline].

  34. Mankarious LA, Bottrill ID, Huchzermeyer PM, et al. Long-term follow-up of submandibular duct rerouting for the treatment of sialorrhea in the pediatric population. Otolaryngol Head Neck Surg. Mar 1999;120(3):303-7. [Medline].

  35. Michel RG, Johnson KA, Patterson CN. Parasympathetic nerve section for control of sialorrhea. Arch Otolaryngol. Feb 1977;103(2):94-7. [Medline].

  36. Pal PK, Calne DB, Calne S, et al. Botulinum toxin A as treatment for drooling saliva in PD. Neurology. Jan 11 2000;54(1):244-7. [Medline].

  37. Parisier SC, Blitzer A, Binder WJ, et al. Tympanic neurectomy and chorda tympanectomy for the control of drooling. Arch Otolaryngol. May 1978;104(5):273-7. [Medline].

  38. Reddihough D, Johnson H, Staples M, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol. Nov 1990;32(11):985-9. [Medline].

  39. Reddihough D, Johnson H, Staples M, et al. Use of benzhexol hydrochloride to control drooling of children with cerebral palsy. Dev Med Child Neurol. Nov 1990;32(11):985-9. [Medline].

  40. Robinson AC, Khoury GG, Robinson PM. Role of irradiation in the suppression of parotid secretions. J Laryngol Otol. Jun 1989;103(6):594-5. [Medline].

  41. Rosen A, Komisar A, Ophir D, et al. Experience with the Wilkie procedure for sialorrhea. Ann Otol Rhinol Laryngol. Sep 1990;99(9 Pt 1):730-2. [Medline].

  42. Scheyer L. Rate of secretion of individual saliva gland pairs under conditions of reduced stimulation. J Appl Physiol. 1955;7:580-2.

  43. Siegel LK, Klingbeil MA. Control of drooling with transdermal scopolamine in a child with cerebral palsy. Dev Med Child Neurol. Nov 1991;33(11):1013-4. [Medline].

  44. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. Jan 2002;112(1):73-81. [Medline].

  45. Talmi YP, Finkelstein Y, Zohar Y. Reduction of salivary flow with transdermal scopolamine: a four-year experience. Otolaryngol Head Neck Surg. Oct 1990;103(4):615-8. [Medline].

  46. Wilkie TF, Brody GS. The surgical treatment of drooling. A ten-year review. Plast Reconstr Surg. Jun 1977;59(6):791-7. [Medline].

Further Reading

Keywords

drooling, sialorrhea, sialorrhoea, ptyalism, cerebral palsy, cognitive impairment, neurological impairment, neurologic impairment, perioral skin breakdown, perioral skin infection, severe mental retardation, hypersecretion of the salivary glands, salivary gland hypersecretion, dysfunctional voluntary oral motor activity, secretory control of the salivary glands

Contributor Information and Disclosures

Author

Neeraj N Mathur, MBBS, MS, Professor, Department of Ear, Nose and Throat, Lady Hardinge Medical College and Associated Smt SK and Kalawati, Saran Children's Hospital, University of Delhi, India; Professor and Head, Department of Ear, Nose and Throat, BP Koirala Institute of Health Sciences, Nepal
Neeraj N Mathur, MBBS, MS is a member of the following medical societies: Association of Otolaryngologists of India, Cochlear Implant Group of India, Indian Medical Association, National Academy of Medical Sciences, India, Neuro-Otologic and Equlibriometric Society of India, and Royal Society of Medicine
Disclosure: Nothing to disclose.

Medical Editor

Jennifer P Porter, MD, Assistant Professor, Department of Otorhinolaryngology, Division of Communicative Science, Chevy Chase Facial Plastic Surgery
Jennifer P Porter, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and Texas Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Karen Hall Calhoun, MD, Professor, Department of Otolaryngology-Head and Neck Surgery, The Ohio State University
Karen Hall Calhoun, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, American Medical Association, American Rhinologic Society, Association for Research in Otolaryngology, Society of University Otolaryngologists-Head and Neck Surgeons, Southern Medical Association, Texas Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo  Consulting; Medvoy Ownership interest Management position

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.